Ark Therapeutics looks for Cerepro partner as CEO steps down
This article was originally published in Scrip
Executive Summary
Ark Therapeutics is no longer looking for a buyer, and instead will pursue a strategy of "selective partnering of programmes together with a plan to monetise certain assets", it said.